| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 3/6 |
Beloningen
Risicoanalyse
Shanghai MicroPort Endovascular MedTech Co., Ltd. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | CN¥98.06 |
| 52 Week Hoogtepunt | CN¥141.14 |
| 52 Week Laag | CN¥78.62 |
| Bèta | 0.36 |
| 11 maand verandering | -13.22% |
| 3 maanden verandering | -0.95% |
| 1 Jaar Verandering | -26.27% |
| 33 jaar verandering | -39.87% |
| 5 jaar verandering | 11.09% |
| Verandering sinds IPO | -7.70% |
Recent nieuws en updates
Recent updates
There's No Escaping Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Muted Earnings Despite A 31% Share Price Rise
Oct 01
Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts
Aug 29Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends
Aug 15Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel
Jun 29These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely
Apr 29Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Apr 09Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't
Mar 25Rendement voor aandeelhouders
| 688016 | CN Medical Equipment | CN Markt | |
|---|---|---|---|
| 7D | -8.4% | -3.5% | -1.2% |
| 1Y | -26.3% | -8.6% | 3.1% |
Rendement versus industrie: 688016 underperformed the CN Medical Equipment industry which returned -8.6% over the past year.
Rendement versus markt: 688016 underperformed the CN Market which returned 3.1% over the past year.
Prijsvolatiliteit
| 688016 volatility | |
|---|---|
| 688016 Average Weekly Movement | 10.4% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in CN Market | 12.0% |
| 10% least volatile stocks in CN Market | 5.4% |
Stabiele aandelenkoers: 688016's share price has been volatile over the past 3 months compared to the CN market.
Volatiliteit in de loop van de tijd: 688016's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2012 | 721 | Qing Zhu | www.endovastec.com |
Shanghai MicroPort Endovascular MedTech Co., Ltd. houdt zich bezig met onderzoek en ontwikkeling, productie en verkoop van aorta en perifere vasculaire medische hulpmiddelen in China en daarbuiten. De producten van het bedrijf omvatten vertakte aorta stent ent systeem, thorax stent ent systeem, abdominale aorta stent ent en toedieningssysteem, bifurcated stent ent systeem, en andere stent ent systeem in chirurgische operatie, evenals accessoires, zoals ballon opblaaskatheter.
Shanghai MicroPort Endovascular MedTech Co., Ltd. Samenvatting
| 688016 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | CN¥12.00b |
| Inkomsten(TTM) | CN¥657.34m |
| Inkomsten(TTM) | CN¥1.27b |
18.3x
Koers/Winstverhouding9.5x
P/S-verhoudingIs 688016 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 688016 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | CN¥1.27b |
| Kosten van inkomsten | CN¥317.93m |
| Brutowinst | CN¥950.38m |
| Overige uitgaven | CN¥293.04m |
| Inkomsten | CN¥657.34m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 5.37 |
| Brutomarge | 74.93% |
| Nettowinstmarge | 51.83% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde 688016 op de lange termijn?
Bekijk historische prestaties en vergelijking